首页> 美国卫生研究院文献>African Health Sciences >Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis

【2h】

Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis

机译：Atazanavir / ritonavir与Lopinavir / ritonavir的组合抗逆转录病毒治疗（购物车）用于HIV-1感染：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

This systematic review and meta-analysis was conducted to evaluate the safety and effectiveness of Atazanavir/ritonavir over lopinavir/ritonavir in human immunodeficiency virus-1 (HIV-1) infection.

机译：进行了这种系统审查和荟萃分析，以评估ATAZANAVIR / Ritonavir对人免疫缺陷病毒-1（HIV-1）感染的Lopinavir / Ritonavir的安全性和有效性。

著录项

期刊名称 African Health Sciences
作者
Bereket Molla Tigabu; Feleke Doyore Agide; Minoo Mohraz; Shekoufeh Nikfar;
展开▼
作者单位

展开▼
年(卷),期 2020(20),1
年度 2020
页码 91–101
总页数 11
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Atazanavir; Atazanavir/ritonavir; lopinavir/ritonavir; viral suppression;

机译：Atazanavir;Atazanavir / Ritonavir;Lopinavir / Ritonavir;病毒抑制;

相似文献

外文文献
中文文献
专利

1. Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling [J] . Sora Yasri, Viroj Wiwanitkit 亚太热带医药杂志（英文版） . 2020,第003期
2. Efficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis [J] . Menshawy Amr, Ismail Ammar, Abushouk Abdelrahman Ibrahim, Archives of virology . 2017,第8期

机译：atazanavir / ritonavir的抗逆转录病毒治疗HIV-1感染受试者的疗效和安全性：系统审查和荟萃分析
3. Efficacy and safety of lopinavir/ritonavir-based antiretroviral therapy in HIV-1-infected subjects with advanced disease: a systematic review and meta-analysis [J] . van Wyk Jean, Fredrick Linda M., Dorr Pat, Future Virology . 2015,第8期

机译：洛匹那韦/利托那韦为基础的抗逆转录病毒疗法在HIV-1感染的晚期疾病患者中的疗效和安全性：系统评价和荟萃分析
4. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial [J] . CahnP., Andrade-VillanuevaJ., ArribasJ.R., The Lancet infectious diseases . 2014,第7期

机译：首次接受HIV-1感染的抗逆转录病毒治疗成人中，使用lopinavir和ritonavir联合拉米夫定的双重疗法与使用lopinavir和ritonavir联合两种核苷逆转录酶抑制剂的三次疗法：随机，开放标签，非劣效性GARDEL试验的48周结果
5. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
6. Validation of a UPLC-MS/MS method for the simultaneous measurement of the antiretroviral drugs atazanavir, darunavir, efavirenz, etravirine, lopinavir, raltegravir, ritonavir from human plasma. [D] . Patel, Rutva. 2012

机译：用于从人血浆中同时测定抗逆转录病毒药物阿扎那韦，达鲁那韦，依非韦伦，依曲韦林，洛匹那韦，拉格列韦，利托那韦的UPLC-MS / MS方法的验证。
7. Long-Term Efficacy Tolerability and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study [O] . Eugénio Teófilo, Nuno Rocha-Pereira, Birger Kuhlmann, -1

机译：一项仍未接受过HIV-1感染的队列研究中基于Atazanavir / Ritonavir的抗逆转录病毒疗法的长期疗效耐受性和肾脏安全性
8. Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis [O] . Bereket Molla Tigabu, Feleke Doyore Agide, Minoo Mohraz, 2020

机译：Atazanavir / ritonavir与Lopinavir / ritonavir的组合抗逆转录病毒治疗（购物车）用于HIV-1感染：系统评价和荟萃分析

Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅